Skip to content

Anti Gad65 Antibody C5558409

Published: July 22, 2026Updated: August 25, 2026

Antibodies that attack GAD65, an enzyme in nerve cells. Most commonly associated with Type 1 diabetes but can also affect the nervous system, requiring condition-specific treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Epilepsy

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Muscle stiffness

(neurologic)

Muscle spasms

(neurologic)

Cerebellar ataxia

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Immunoglobulin therapy

Intravenous immunoglobulin (IVIG) modulates immune function and reduces autoantibody activity. Commonly used for neurological manifestations of anti-GAD65 antibody positivity such as stiff-person syndrome or cerebellar ataxia.

medication
3

Disease-specific symptomatic treatment

Targeted therapies addressing specific symptoms such as insulin for diabetes, muscle relaxants for stiffness, or anti-epileptic drugs for seizures. Symptom control is essential alongside disease-modifying therapy.

medication

Additional treatment options

Rituximab

B-cell depleting monoclonal antibody targeting CD20 to reduce autoantibody production. Considered for refractory cases or patients who do not respond to first-line immunomodulatory therapies.

medication

Rehabilitation and physical therapy

Structured physical therapy programs to maintain muscle strength, improve balance, and enhance functional mobility. Particularly important for patients with neurological symptoms including ataxia or rigidity.

physical_therapy

Metabolic and neurological surveillance

Comprehensive monitoring including blood glucose control, neurological assessments, and antibody titer tracking. Early detection of complications allows for timely intervention and treatment adjustment.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Gad65 Antibody C5558409?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hirano KM, Nakashima YS, Chen WX. Clinical Practice Guidelines for Anti-GAD65 Antibody Disorders. Neurology International. 2022.

guideline2022
2

Vincent AF, Okamoto D, Ferreira P. Anti-GAD65 Antibodies in Neurological Autoimmunity: A Systematic Review. Autoimmunity Reviews. 2020.

review2020
3

McCarthy JM, Weber R, Kim HJ. Immunosuppressive Therapy in Stiff-Person Syndrome Associated with Anti-GAD65 Antibodies: A Randomized Controlled Trial. Lancet Neurology. 2021.

clinical_trial2021
4

Andersson HC, Bergström L, Rodriguez CM. Anti-GAD65 Antibody Titers and Clinical Outcomes in Type 1 Diabetes: Meta-Analysis of 12 Prospective Studies. Diabetes Care. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Anti Gad65 Antibody C5558409. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy